Moderna Stock Falls
In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
Vaccine manufacturer Moderna has welcomed the Chancellor's announcements regarding major infrastructure schemes.
At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...
The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.
Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...
10don MSN
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback